Choi Jae-mun, CEO of Calici Co., Ltd., introduced the technological capabilities and vision of the AI-based drug discovery platform “Pharmaco-Net” in an interview with Monthly People.
The interview highlighted achievements in AI-driven candidate compound discovery, collaboration cases with domestic and international research institutions, and Calici’s approach to improving research efficiency.
It also emphasized the company’s philosophy that AI should not replace researchers, but rather serve as a decision-support tool, along with its strategy for growth in the global drug development ecosystem.